Siemens Healthineers AG - Special Call

Group 1 - The company is preparing for Q4 fiscal year 2025, aiming to align all stakeholders before entering a silent period [1] - There has been a significant 6% devaluation of the U.S. dollar, which is expected to create negative translational headwinds on revenue for the full quarter [2] - The company anticipates that growth excluding foreign exchange effects will exceed nominal growth due to the currency fluctuations [2] Group 2 - The previous outlook for comparable revenue growth was set between 5.5% and 6%, with adjusted EPS expected to range from EUR 2.30 to EUR 2.45 [3] - Q4 is projected to be the strongest quarter in absolute terms, although it is expected to be less loaded compared to the previous year's Q4 [3]